Suppr超能文献

治疗精神分裂症或抑郁症患者的大麻使用问题:系统评价。

Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.

机构信息

Centre for Brain and Mental Health Research, University of Newcastle, University Dr, Callaghan, NSW 2308, Australia.

出版信息

J Clin Psychiatry. 2010 Mar;71(3):247-54. doi: 10.4088/JCP.09r05119gry.

Abstract

OBJECTIVE

This article systematically reviews the evidence from randomized controlled trials (RCTs) for pharmacologic and psychological approaches to the treatment of cannabis use among individuals with psychotic or depressive disorders.

DATA SOURCES

A systematic literature search was conducted using the PubMed and PsychINFO databases from inception to December 2008. Individual searches in cannabis use (search terms: marijuana, cannabis, marijuana abuse, cannabis abuse, marijuana usage, cannabis usage), mental disorders (search terms: mood disorders, affective disorders, anxiety disorders, anxiety, depressive disorder, depression, psychotic disorders, psychosis, mental disorders), and pharmacotherapy (search terms: medication, drug therapy, pharmacotherapy, psychopharmacology, clinical trials, drug trial, treatment trial) were conducted and limited to humans, adolescents and adults.

STUDY SELECTION

A search combining the individual cannabis use, mental disorder and pharmacotherapy searches produced 1,713 articles (PubMed = 1,398; PsychINFO = 315). Combining the cannabis use and mental disorder searches while limiting them to English articles and RCTs produced a total of 286 articles (PubMed = 228; PsychINFO = 58). From this literature, there were 7 RCTs conducted among mental health clients that reported cannabis use outcomes using pharmacologic or psychological interventions.

DATA SYNTHESIS

While few RCTs have been conducted, there is evidence that pharmacologic and psychological interventions are effective for reducing cannabis use in the short-term among people with psychotic disorders or depression.

CONCLUSIONS

Although it is difficult to make evidence-based treatment recommendations due to the paucity of research in this area, available studies indicate that effectively treating the mental health disorder with standard pharmacotherapy may be associated with a reduction in cannabis use and that longer or more intensive psychological interventions rather than brief interventions may be required, particularly among heavier users of cannabis and those with more chronic mental disorders. Specific recommendations regarding the type and length of specific psychological treatments cannot be made at this time, although motivational interviewing and cognitive-behavioral therapy approaches appear most promising.

摘要

目的

本文系统地回顾了随机对照试验(RCT)中针对精神障碍或抑郁障碍个体的大麻使用进行药物和心理治疗的证据。

资料来源

从开始到 2008 年 12 月,使用 PubMed 和 PsychINFO 数据库进行了系统的文献检索。大麻使用(搜索词:大麻,大麻,大麻滥用,大麻滥用,大麻使用,大麻使用)、精神障碍(搜索词:心境障碍,情感障碍,焦虑障碍,焦虑,抑郁障碍,抑郁症,精神障碍)和药物治疗(搜索词:药物,药物治疗,药物治疗,精神药理学,临床试验,药物试验,治疗试验)的个体搜索,并仅限于人类,青少年和成年人。

研究选择

将个体的大麻使用,精神障碍和药物治疗搜索结合起来,共产生了 1713 篇文章(PubMed = 1398;PsychINFO = 315)。将大麻使用和精神障碍搜索结合起来,并将其限制为英文文章和 RCT,共产生了 286 篇文章(PubMed = 228;PsychINFO = 58)。从这些文献中,有 7 项 RCT 是针对心理健康患者进行的,这些患者使用药物或心理干预措施报告了大麻使用结果。

数据综合

虽然进行的 RCT 很少,但有证据表明,药物和心理干预措施在短期内可有效减少精神障碍或抑郁症患者的大麻使用。

结论

尽管由于该领域研究匮乏,难以提出循证治疗建议,但现有研究表明,用标准药物治疗有效治疗精神健康障碍可能与减少大麻使用有关,而且可能需要更长或更密集的心理干预,而不是简短的干预,特别是在大麻使用量较大和精神障碍较慢性的患者中。目前还不能针对特定类型和长度的具体心理治疗提出具体建议,尽管动机性访谈和认知行为治疗方法似乎最有希望。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验